| scholarly article | Q13442814 |
| P356 | DOI | 10.3748/WJG.V16.I37.4652 |
| P953 | full work available at URL | https://doi.org/10.3748/wjg.v16.i37.4652 |
| https://europepmc.org/articles/PMC2951515 | ||
| https://europepmc.org/articles/PMC2951515?pdf=render | ||
| P932 | PMC publication ID | 2951515 |
| P698 | PubMed publication ID | 20872965 |
| P5875 | ResearchGate publication ID | 50346737 |
| P2093 | author name string | Wei An | |
| Yu-Tao Zhan | |||
| P2860 | cites work | The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease | Q28278958 |
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Epidemiology of non-alcoholic fatty liver disease in China. | Q30373353 | ||
| The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet | Q30657764 | ||
| In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats | Q30960436 | ||
| Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients | Q33308506 | ||
| Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke | Q33526964 | ||
| Natural killer group 2 member D, its ligands, and liver disease: good or bad? | Q33563338 | ||
| Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. | Q33781288 | ||
| Innate and adaptive lymphoid cells in the human liver | Q33916563 | ||
| Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. | Q34060210 | ||
| Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy | Q34175390 | ||
| Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines | Q34467338 | ||
| Non-alcoholic fatty liver disease: a brief review | Q34554882 | ||
| Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. | Q34605137 | ||
| Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation | Q34744890 | ||
| Hepatic fibrosis--role of hepatic stellate cell activation | Q35017363 | ||
| Recent insights into the role of the innate immune system in the development of alcoholic liver disease. | Q35216526 | ||
| Importance of Kupffer cells for T-cell-dependent liver injury in mice | Q35829575 | ||
| Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. | Q35832836 | ||
| To be or not to be NKT: natural killer T cells in the liver. | Q35919440 | ||
| Innate immunity in the liver | Q36036373 | ||
| Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis | Q36168809 | ||
| Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease | Q36179090 | ||
| Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. | Q36369031 | ||
| Pathophysiology of nonalcoholic steatohepatitis | Q36422705 | ||
| TLR-dependent cross talk between human Kupffer cells and NK cells | Q36446960 | ||
| Feeding our immune system: impact on metabolism | Q36494499 | ||
| Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis | Q36669223 | ||
| Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients | Q36727795 | ||
| Liver fibrosis: searching for cell model answers | Q36777935 | ||
| Role of mitochondria in non-alcoholic fatty liver disease | Q36849037 | ||
| The roles of innate immune cells in liver injury and regeneration. | Q36926021 | ||
| Cell signaling in oxidative stress-induced liver injury | Q36989693 | ||
| The trafficking of natural killer cells | Q36990612 | ||
| Liver: An organ with predominant innate immunity | Q37048206 | ||
| Hepatic NKT cells: friend or foe? | Q37095527 | ||
| Innate immunity and alcoholic liver fibrosis | Q37108845 | ||
| Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis | Q37144593 | ||
| Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment | Q37149405 | ||
| Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. | Q37192623 | ||
| Kupffer cells in non-alcoholic fatty liver disease: the emerging view. | Q37222183 | ||
| Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. | Q37224653 | ||
| Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis | Q37346066 | ||
| Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection | Q37349879 | ||
| Immunopathogenesis of psoriasis: focus on natural killer T cells. | Q37488601 | ||
| Signal molecule-mediated hepatic cell communication during liver regeneration | Q37649635 | ||
| Nonalcoholic fatty liver disease: pathology and pathogenesis | Q37676210 | ||
| Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage | Q38314701 | ||
| Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping | Q38315752 | ||
| Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease | Q38320784 | ||
| Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease | Q38336352 | ||
| Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease | Q38358419 | ||
| Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines | Q39552195 | ||
| Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages | Q39990946 | ||
| Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease | Q40048380 | ||
| Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function | Q40550711 | ||
| Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. | Q41644055 | ||
| Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats | Q41825863 | ||
| Natural killer T cells and non-alcoholic fatty liver disease: fat chews on the immune system. | Q41983252 | ||
| Pathogenic roles of tumor necrosis factor receptor p55-mediated signals in dimethylnitrosamine-induced murine liver fibrosis. | Q43988767 | ||
| Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta | Q44129305 | ||
| Energy restriction restores the impaired immune response in overweight (cafeteria) rats | Q44953669 | ||
| Production of protective gamma interferon by natural killer cells during early mouse hepatitis virus infection | Q45387365 | ||
| Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells | Q45401996 | ||
| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. | Q46085888 | ||
| NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis | Q46141816 | ||
| Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice | Q46455710 | ||
| Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners | Q46939919 | ||
| Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. | Q46974412 | ||
| Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. | Q50590704 | ||
| Relation between the fatty acid composition of peripheral blood mononuclear cells and measures of immune cell function in healthy, free-living subjects aged 25–72 y | Q51536857 | ||
| Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. | Q51752154 | ||
| Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). | Q52560974 | ||
| Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses. | Q52922958 | ||
| Kupffer cells and hepatocyte metabolism: a two-way street? | Q53419419 | ||
| Impairment of natural killer (NK) cells is an important factor in a weak Th1-like response in irradiated mice. | Q53561155 | ||
| Inactivation of Kupffer cells prevents early alcohol-induced liver injury | Q72094198 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18 | Q74108232 | ||
| Nonalcoholic steatohepatitis | Q74424858 | ||
| Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients | Q77318114 | ||
| Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways | Q77320295 | ||
| Proteolysis but not ICAM-1 expression in fatty liver increased in tissue harvesting--role of Kupffer cells | Q79099589 | ||
| Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease | Q79269614 | ||
| Prevention of hepatic fibrosis in nonobese diabetic mice: a critical role for interferon-gamma | Q80215336 | ||
| Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men | Q80709947 | ||
| Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease | Q83166566 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | innate immune response | Q428253 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 4652-4660 | |
| P577 | publication date | 2010-10-01 | |
| 2010-10-07 | |||
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Roles of liver innate immune cells in nonalcoholic fatty liver disease | |
| P478 | volume | 16 |
| Q34465368 | Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation |
| Q50615299 | Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. |
| Q36245960 | Animal Models Correlating Immune Cells for the Development of NAFLD/NASH. |
| Q41435356 | Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis |
| Q90302599 | Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study |
| Q36967242 | C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis |
| Q34988970 | Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation |
| Q33755829 | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation |
| Q38959199 | Expression of mediators of purinergic signaling in human liver cell lines. |
| Q34041838 | GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes |
| Q37375305 | Glycosyltransferase GLT8D2 positively regulates ApoB100 protein expression in hepatocytes |
| Q26764913 | Glycosyltransferases and non-alcoholic fatty liver disease |
| Q41814282 | HIV Infection and TLR Signalling in the Liver |
| Q92837973 | High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis |
| Q35875848 | Human immunodeficiency virus infection and the liver |
| Q39077154 | IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet |
| Q27025620 | IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression |
| Q38161295 | Immune cells and metabolic dysfunction |
| Q57210121 | Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH |
| Q50516235 | Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis. |
| Q51280945 | Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. |
| Q35588261 | Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liver |
| Q101038851 | MiR-155/GSK-3β mediates anti-inflammatory effect of Chikusetsusaponin IVa by inhibiting NF-κB signaling pathway in LPS-induced RAW264.7 cell |
| Q24563068 | Non-alcoholic fatty liver disease: what the clinician needs to know |
| Q22299426 | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals |
| Q28071596 | Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells |
| Q53063351 | Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide. |
| Q33886918 | Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis |
| Q34431785 | RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice |
| Q26998093 | Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? |
| Q41863806 | STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice |
| Q86090696 | Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease |
| Q33907632 | Steatosis and steatohepatitis: complex disorders |
| Q27010291 | Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology |
| Q30382395 | The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. |
| Q26784452 | The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease |
| Q34003187 | The effect of citrus peel extracts on cytokines levels and T regulatory cells in acute liver injury. |
| Q33831012 | The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice |
| Q37581353 | The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner |
| Q38107674 | The role of the complement system in metabolic organs and metabolic diseases |
| Q38900456 | Virologic and immunologic aspects of HIV-hepatitis C virus coinfection |
| Q48234451 | iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. |
Search more.